Cytoreductive nephrectomy in the current treatment algorithm.

Kuusk, Teele; Szabados, Bernadett; Liu, Wing Kin; Powles, Thomas; Bex, Axel

Kuusk, Teele; Szabados, Bernadett; Liu, Wing Kin; Powles, Thomas; Bex, Axel.

Afiliação

Kuusk T; Royal Free Hospital, Department of Urology, Renal Cancer Unit, London, UK.
Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.
Liu WK; Royal Free Hospital, Department of Medical Oncology, London, UK.
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.
Bex A; Royal Free Hospital, Department of Urology, Renal Cancer Unit, University College London, Division of Surgical and Interventional Sciences, London, UK.

Ther Adv Med Oncol ; 11: 1758835919879026, 2019.

Article em En | MEDLINE | ID: mdl-31632471

Palavras-chave

cytoreductive nephrectomy; immunotherapy; metastatic renal cell carcinoma; renal cell carcinoma; sunitinib; systemic therapy; targeted therapy; tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article